Ultralife Financials - Benzinga

Ultralife Corp

ULBINASDAQ

Trade with Public

Trade with Public

$5.76

0.203.6%

Últ. Act.: Sep 11, 9:21 AM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivoFinanzasSentimiento Propiedad Comparar Informe de acciones

Ultralife Financials

Ultralife (ULBI) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
CORRECTION: Ultralife Q2 EPS $0.15 Up From $0.05 YoY, Sales $47.943M Down From $48.561M YoY

Ultralife (NASDAQ:ULBI) reported quarterly earnings of $0.15 per share. This is a 200 percent increase over earnings of $0.05 per share from the same period last year. The company reported $47.943 million in sales this

Benzinga Newsdesk

PRO
Ultralife Q1 EPS $(0.03) Misses $0.15 Estimate, Sales $47.445M Miss $52.400M Estimate

Ultralife (NASDAQ:ULBI) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $0.15 by 120 percent. This is a 123.08 percent decrease over earnings of $0.13 per share from the same

Benzinga Newsdesk

Earnings Scheduled For March 10, 2026

Benzinga Insights

Ultralife Earnings Report: Q4 Overview

Benzinga Insights

PRO
Ultralife Q4 Adj. EPS $0.12 Misses $0.27 Estimate, Sales $48.481M Miss $57.000M Estimate

Ultralife (NASDAQ:ULBI) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.27 by 55.56 percent. This is a 1100 percent increase over earnings of $0.01 per share from the same

Benzinga Newsdesk

A Peek at Ultralife's Future Earnings

Benzinga Insights

© 2026 Benzinga | All Rights Reserved